Not on their own. If you're wondering whether a weight-loss peptide that works in mice will work in you, the study's own authors say it is not known yet. Mice and minipigs show you how a peptide behaves in those animals. They can't tell you what it will do in a person.
You may have seen BRP called a “natural Ozempic.” That is a headline phrase, not a product category. BRP is a human-derived peptide found by computer search, not an herb or supplement, and it is not available to anyone right now. So this is about what the research can and can't carry over to you.
What the BRP study found in animals
Stanford Medicine's release on BRP describes a 12-amino-acid peptide that a computer program, Peptide Predictor, picked out of human genes. In lab-grown nerve cells, GLP-1 raised activity threefold. BRP raised it tenfold.
The animal work came next. Lean mice and minipigs received BRP by muscle injection before a meal. Over the next hour, food intake dropped by up to 50% in both animals. Minipigs were used because they “more closely mirror human metabolism and eating patterns than mice do.”
Obese mice got daily injections for 14 days. They lost about 3 grams on average, nearly all of it fat, while untreated mice gained about 3 grams. Their glucose and insulin tolerance improved. Movement, water intake, anxiety-like behavior and fecal output showed no differences from controls.
Keep those numbers in their time frame. That is one hour of eating and two weeks in mice. A 3-gram change in a mouse does not translate into a pound figure for you.
Why animal results don't automatically carry over to people
The study's authors name the gap. They don't know whether people would see comparable effects. Nausea can't be judged from animals, and nausea is one of the common complaints people report with GLP-1 medications. The receptors that recognize BRP are not yet identified. Peptides also break down quickly, so a longer-lasting version may be needed.
For the broader reasons animal results can fail to hold in people, read why animal results may not hold in people (our research library). A 2021 review of antibiofilm peptides, indexed by the U.S. National Library of Medicine, is about bacterial infections rather than weight. It does discuss the pros and cons of mouse models for assessing peptides, and the key challenges of translating peptides to the clinic.
What animal data can show you, and what only human trials can
| Question | What animal data can show | What only human trials can answer |
|---|---|---|
| Does it reduce food intake in a short test? | Yes, in lean mice and minipigs: up to 50% less food over the next hour | Whether people eat less, and by how much |
| Does weight change over days? | Obese mice lost about 3 grams in 14 days, nearly all fat | Pounds lost by people, and over what time |
| Where does it act? | BRP appears to act in the hypothalamus; semaglutide's targets also sit in the gut, pancreas and other tissues | Whether BRP acts the same way in people, since its receptors are not yet identified |
| Side effects like nausea | No differences in movement, water intake, anxiety-like behavior or fecal output | Nausea cannot be judged from animals |
| Safety, effectiveness and dose in people | Only the animal findings above | Clinical trials, which the study says must establish all three |
What has to happen before BRP can be judged for people
The researchers list three next steps: find the cell-surface receptors that bind BRP, work out how to make its effects last longer, and run clinical trials to establish safety, effectiveness and dose. Senior author Katrin Svensson put the goal this way: “We are very eager to learn if it is safe and effective in humans.”
Svensson and lead author Laetitia Coassolo are inventors on patents on BRP peptides for metabolic disorders. Svensson also co-founded a company to move BRP toward human trials. Keep that in mind when you read headlines about it.
Is BRP the strongest peptide for weight loss?
There is no strongest peptide to name from this study. Svensson said, “Nothing we've tested before has compared to semaglutide's ability to decrease appetite and body weight.” The Stanford release does not rank BRP against other peptides in people.
The most useful difference is where each one acts. Semaglutide's receptors are found in the brain, gut, pancreas and other tissues. BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism.
Your options, and who each one fits
| Option | What the evidence says | Who it fits |
|---|---|---|
| BRP | Studied only in mice and minipigs so far; human safety and dose are unknown | No one yet. It is not available, so watch for trial news |
| Semaglutide and other GLP-1 medications (Ozempic, Wegovy) | The AMA says these are well studied and have established guidelines | People a clinician judges to be candidates, such as those with diabetes, obesity or other chronic conditions that contribute to long-term weight gain |
| Newer injectable peptides sold for wellness | Mostly animal studies; the AMA says there is nothing substantial showing these results translate to humans | The AMA advises talking with a physician before using any of them |
What are the downsides of weight loss peptides?
The AMA's article What doctors want patients to know about injectable peptides quotes family and sports medicine physician Anthony C. Tam, MD. For newer injectable peptides, he says side effects may include injection-site reactions, fatigue, headaches and gastrointestinal symptoms. He also says there is minimal evidence on the side effects of long-term or frequent dosing.
For GLP-1 medications, Tam lists nausea, upset stomach, diarrhea and constipation, along with a risk of pancreatitis. The same article says many newer injectable peptides are not FDA approved, and that some are sold at wellness spas, online sites and through the grey market.
What to do next
- Check whether a result came from animals or people. The BRP findings come from mice and minipigs.
- Ask whether any product you're considering is FDA approved. The AMA says many newer injectable peptides are not.
- Talk with a clinician before using any injectable peptide. Tam says talking it through “can help you make a safer, more informed decision.”
If you're still comparing options, your guide to healthy weight loss and best weight loss plan for you set the choices side by side, so you can bring sharper questions to your next appointment.
By the Gym Floor Guide Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.